Nasdaq Biotechnology Ishares (IBB) 235.08 $IBB
A Small-Cap Biotech Stock on the Verge of a Breakout
at The Street - Wed Apr 09, 1:58PM CDT
This small-cap biotech stock should be on your trading radar.
'Fast Money' Recap: S&P Snapback
at The Street - Wed Apr 09, 4:00AM CDT
The trading panel discussed whether investors can trust this latest rlly.
Shares of IBB Down 11.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Apr 07, 10:01AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 4 weeks, iShares Nasdaq Biotechnology Index has returned 11.33% as of today's recent price of $228.98.
Is Biotech in a Bubble? The Bear Case Explained
Chris Ahlstrand, The Motley Fool - Motley Fool - Fri Apr 04, 8:30AM CDT
The rumblings of a biotech bubble are getting louder as the Nasdaq Biotech Index has declined about 14% from its peak of $275.40 on February 25th. The recent volatility is a phenomenon that has not been seen in quite some time in the space. So is...
3 Biggest Biotech Crashes in March
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but the drop in some biotech stocks was simply breathtaking . Celldex Therapeutics , Acceleron , and Newlink Genetics all tumbled more than 25% last month -- far more than the 10% drop in the ...
3 Stocks That Escaped Biotech's March Madness
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but there were a few biotech stocks that soared. Among them were Agios Pharmaceuticals , Chimerix, Inc. , and Portola Pharmaceuticals . All three shrugged off the broad biotech sell-off that...
Can ANI Pharmaceuticals, Inc. Beat the Biotech Bubble?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 02, 8:30AM CDT
After last Friday's volatile session, biotechs are now barely in the green for the year, having given back nearly all of their gains. Specifically, the iShares Biotechnology Index had been up over 20% earlier this year, but it can now only lay...
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.22% Gain
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.22% Yesterday
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Any Survivors from the Biotech ETF Meltdown? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 3:00PM CDT
Although all biotech ETFs crumbled last week, many might still be well positioned for the future.
Three Oversold BioTechs for Tired Gamblers: StockTwits.com
at The Street - Mon Mar 31, 10:47AM CDT
Investors seek to play with big-name biotechs after this month's sell-off in the sector. Here are three names that don't promise the lottery payouts of successful small caps, but don't demand betting the house on one drug awaiting approval.
iShares Nasdaq Biotechnology Index Has Returned 9.8% Since SmarTrend Recommendation (IBB)
Comtex SmarTrend(R) - Mon Mar 31, 9:31AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 3 weeks, iShares Nasdaq Biotechnology Index has returned 9.79% as of today's recent price of $232.96.
Why GlaxoSmithKline PLC Shrugged Off Alli's Recall
George Budwell, The Motley Fool - Motley Fool - Sun Mar 30, 3:30PM CDT
GlaxoSmithKline announced a voluntary recall in the United States and Puerto Rico of its over-the-counter, or OTC, fat-blocking pill Alli last Thursday, after consumers in seven states reported that they had bought bottles containing pills that...
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 2.86% Sell Off
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.86% Loss
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Poof! Biotech's 2014 Outperformance is Gone
at The Street - Fri Mar 28, 3:16PM CDT
Biotech stocks continue to melt down. I know, broken record, but like a car wreck, it's hard not to look.
A Speculative Biotech Catalyst Trade: ORMP
at The Street - Fri Mar 28, 8:23AM CDT
This beaten-down biotech stock could be ripe for a rebound.
3 Biotechs Falling Like a Knife: Arrowhead, Celldex, Receptos
George Budwell, The Motley Fool - Motley Fool - Wed Mar 26, 5:30PM CDT
By all accounts, biotech has had a rough week. The iShares Nasdaq Biotechnology Index is down more than 8%, and concerns over a bubble abound. Yet some companies are falling much faster than the broader sector. Are these companies becoming value...
A Small-Cap Biotech Stock With Promise: MSTX
at The Street - Wed Mar 26, 1:55PM CDT
This small-cap biotech stock could be setting up for a great buying opportunity here following the massive selloff in the space.
A Small-Cap Biotech Stock on the Verge of a Breakout
at The Street - Wed Apr 09, 1:58PM CDT
This small-cap biotech stock should be on your trading radar.
'Fast Money' Recap: S&P Snapback
at The Street - Wed Apr 09, 4:00AM CDT
The trading panel discussed whether investors can trust this latest rlly.
Shares of IBB Down 11.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Apr 07, 10:01AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 4 weeks, iShares Nasdaq Biotechnology Index has returned 11.33% as of today's recent price of $228.98.
Is Biotech in a Bubble? The Bear Case Explained
Chris Ahlstrand, The Motley Fool - Motley Fool - Fri Apr 04, 8:30AM CDT
The rumblings of a biotech bubble are getting louder as the Nasdaq Biotech Index has declined about 14% from its peak of $275.40 on February 25th. The recent volatility is a phenomenon that has not been seen in quite some time in the space. So is...
3 Biggest Biotech Crashes in March
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but the drop in some biotech stocks was simply breathtaking . Celldex Therapeutics , Acceleron , and Newlink Genetics all tumbled more than 25% last month -- far more than the 10% drop in the ...
3 Stocks That Escaped Biotech's March Madness
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but there were a few biotech stocks that soared. Among them were Agios Pharmaceuticals , Chimerix, Inc. , and Portola Pharmaceuticals . All three shrugged off the broad biotech sell-off that...
Can ANI Pharmaceuticals, Inc. Beat the Biotech Bubble?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 02, 8:30AM CDT
After last Friday's volatile session, biotechs are now barely in the green for the year, having given back nearly all of their gains. Specifically, the iShares Biotechnology Index had been up over 20% earlier this year, but it can now only lay...
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.22% Gain
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.22% Yesterday
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Any Survivors from the Biotech ETF Meltdown? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 3:00PM CDT
Although all biotech ETFs crumbled last week, many might still be well positioned for the future.
Three Oversold BioTechs for Tired Gamblers: StockTwits.com
at The Street - Mon Mar 31, 10:47AM CDT
Investors seek to play with big-name biotechs after this month's sell-off in the sector. Here are three names that don't promise the lottery payouts of successful small caps, but don't demand betting the house on one drug awaiting approval.
iShares Nasdaq Biotechnology Index Has Returned 9.8% Since SmarTrend Recommendation (IBB)
Comtex SmarTrend(R) - Mon Mar 31, 9:31AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 3 weeks, iShares Nasdaq Biotechnology Index has returned 9.79% as of today's recent price of $232.96.
Why GlaxoSmithKline PLC Shrugged Off Alli's Recall
George Budwell, The Motley Fool - Motley Fool - Sun Mar 30, 3:30PM CDT
GlaxoSmithKline announced a voluntary recall in the United States and Puerto Rico of its over-the-counter, or OTC, fat-blocking pill Alli last Thursday, after consumers in seven states reported that they had bought bottles containing pills that...
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 2.86% Sell Off
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.86% Loss
Comtex SmarTrend(R) - Fri Mar 28, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $228.69 to a high of $238.54. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $228.72 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Poof! Biotech's 2014 Outperformance is Gone
at The Street - Fri Mar 28, 3:16PM CDT
Biotech stocks continue to melt down. I know, broken record, but like a car wreck, it's hard not to look.
A Speculative Biotech Catalyst Trade: ORMP
at The Street - Fri Mar 28, 8:23AM CDT
This beaten-down biotech stock could be ripe for a rebound.
3 Biotechs Falling Like a Knife: Arrowhead, Celldex, Receptos
George Budwell, The Motley Fool - Motley Fool - Wed Mar 26, 5:30PM CDT
By all accounts, biotech has had a rough week. The iShares Nasdaq Biotechnology Index is down more than 8%, and concerns over a bubble abound. Yet some companies are falling much faster than the broader sector. Are these companies becoming value...
A Small-Cap Biotech Stock With Promise: MSTX
at The Street - Wed Mar 26, 1:55PM CDT
This small-cap biotech stock could be setting up for a great buying opportunity here following the massive selloff in the space.
